Brief: Akoya Biosciences Q3 EPS USD -0.26
08/11/2023 21:00
Nov 08 (Reuters) - Akoya Biosciences Q3 gross profit USD 15.276 million. * Q3 revenue USD 18.048 million vs. IBES estimate USD 24.5 million * Q3 gross margin 60.6% * outlook FY revenue USD 95-98 million
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks